Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk-Reference-Cited by-同舟云学术

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

Published:2021-10-28 Issue:18 Volume:385 Page:1643-1655
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Valgimigli Marco¹^ORCID,Frigoli Enrico¹,Heg Dik¹,Tijssen Jan¹,Jüni Peter¹,Vranckx Pascal¹,Ozaki Yukio¹,Morice Marie-Claude¹,Chevalier Bernard¹,Onuma Yoshinobu¹,Windecker Stephan¹,Tonino Pim A.L.¹,Roffi Marco¹,Lesiak Maciej¹,Mahfoud Felix¹,Bartunek Jozef¹,Hildick-Smith David¹,Colombo Antonio¹,Stanković Goran¹,Iñiguez Andrés¹,Schultz Carl¹,Kornowski Ran¹,Ong Paul J.L.¹,Alasnag Mirvat¹,Rodriguez Alfredo E.¹,Moschovitis Aris¹,Laanmets Peep¹,Donahue Michael¹,Leonardi Sergio¹,Smits Pieter C.¹

Affiliation:

1. From the Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Università della Svizzera Italiana, Lugano (M.V.), CTU Bern, University of Bern (E.F., D.H.), and the Department of Cardiology, Bern University Hospital (S.W.), Bern, the Division of Cardiology, Geneva University Hospitals, Geneva (M.R.), and HerzZentrum Hirslanden Zürich, Zurich (A.M.) — all in Switzerland; the Department of Cardiology, Amsterdam University Medical Centers, Amsterdam (J.T.), European Cardiovascular Research Institute (J...

Funder

Terumo

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2108749

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program;The American Journal of Cardiology;2024-03

2. Effect of chemotherapy in tumor on coronary arteries: Mechanisms and management;Life Sciences;2024-02

3. Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria;International Journal of Cardiology;2024-02

4. Geographical variations in the effectiveness and safety of abbreviated or standard antiplatelet therapy after PCI in patients at high bleeding risk;Canadian Journal of Cardiology;2024-02

5. After placement of a newer-generation drug-eluting coronary artery stent in a patient with a high bleeding risk, does one month of dual antiplatelet therapy effectively reduce the incidence of major bleeding while also maintaining stent effectiveness?;Evidence-Based Practice;2024-01-25